Israeli firm Betalin Therapeutics has an implantable micro-pancreas that can produce insulin in patients with diabetes. The biological scaffolding combined with insulin producing cells is an\u00a0engineered micro-pancreas. It is therefore implanted in a person during a minimally invasive procedure. Betalin's head researcher Avi Treves says the implanted device has the ability to produce insulin in response to blood glucose levels. However, the technology was successful in animal studies and are now raising money for human trials.\r\n\r\nRead full article here!